Human-derived collagen injection during arthroscopic rotator cuff repair improved structural markers on imaging (lower Sugaya grades, greater tendon elasticity) but produced no clinically meaningful improvements in pain, function, or range of motion compared to standard repair alone.
Rotator cuff tears represent one of the most common shoulder injuries, affecting millions globally. While arthroscopic repair is a standard surgical approach, re-tears occur in up to 20-30% of cases, limiting long-term outcomes. This has prompted researchers to investigate augmentation strategies, including biologic scaffolds. A new randomized controlled trial published in Clinics in Orthopedic Surgery examined whether injecting human-derived collagen during repair could improve healing.
The study enrolled 60 patients with full-thickness rotator cuff tears, randomly assigning 30 to receive human-derived collagen injection at the repair site and 30 to undergo standard repair alone. The collagen was applied between the tendon and its footprint (attachment point on bone) as well as into the tendon matrix itself. Researchers tracked both clinical outcomes (pain, function, range of motion) and structural outcomes (imaging findings, tissue mechanics) over the follow-up period. Forty-five patients completed the study: 23 in the collagen group and 22 in the control group.
The gap between structural and clinical findings was striking. On structural assessment, the collagen group showed meaningful improvements. MRI-based Sugaya classification scores (measuring structural integrity on a scale where lower is better) were significantly lower in the collagen group (1.94 vs. 2.79, p = 0.003). Shear wave elastography, which measures tissue stiffness and elasticity, revealed greater tendon elasticity at the repair footprint in the collagen group (9.23 vs. 6.87 kPa, p = 0.001). Re-tear rates were numerically lower in the collagen group (4.3% vs. 9.1%), though this difference did not reach statistical significance.
However, these structural advantages failed to translate into patient-reported benefits. Pain scores (measured on a visual analog scale), functional outcome scores (Constant, UCLA, ASES, and Simple Shoulder Test), and range of motion showed no significant differences between groups at final follow-up. Notably, external rotation was actually significantly reduced in the collagen group (47.4 degrees vs. 56.2 degrees, p = 0.015), suggesting a potential clinical drawback. This discordance between tissue-level improvements and functional outcomes represents the study's central finding: better-looking tissue on imaging did not produce better-functioning shoulders in patients.
If you are considering rotator cuff surgery, this evidence does not yet justify seeking out collagen augmentation as a way to improve your functional recovery. While the structural imaging improvements are real and potentially encouraging for long-term durability, the lack of clinical benefit in pain, strength, and range of motion is a major limitation. The reduction in external rotation in the collagen group is particularly concerning and warrants further investigation.
The study is appropriately conservative in its conclusions: it suggests human-derived collagen may alter tissue biology in measurable ways, but the clinical significance remains uncertain. Larger, longer-term follow-up studies would be needed to determine whether structural improvements eventually translate into reduced re-tear rates or delayed functional decline after surgery. For now, standard arthroscopic repair remains the evidence-based approach, and individual decisions about augmentation should involve discussion with your surgical team about the specific tear characteristics and risk factors in your case.
| Attribute | Details |
|---|---|
| Study Type | Prospective randomized controlled trial |
| Sample Size | 60 enrolled, 45 completed analysis |
| Groups | Human-derived collagen injection (n=23) vs. Standard repair control (n=22) |
| Primary Outcomes | Functional scores (Constant, UCLA, ASES, SST), pain (VAS), range of motion |
| Secondary Outcomes | Sugaya classification on MRI, tendon elasticity on shear wave elastography |
| Follow-up Duration | Not explicitly stated in abstract |
| Key Finding | Improved structural markers (MRI grades, elasticity) without clinical benefit in pain or function |
| Notable Adverse Finding | Reduced external rotation in collagen group (p=0.015) |
| Re-tear Rate | 4.3% (collagen) vs. 9.1% (control), not statistically significant |
| Journal | Clinics in Orthopedic Surgery |
| Quality Consideration | Single-center, single-blind design; modest sample size; completion rate 75% |
Clinics in Orthopedic Surgery. Effect of human-derived collagen injection on clinical and structural outcomes after arthroscopic rotator cuff repair: A prospective randomized controlled trial. PubMed ID: 42226781
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.